Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Pirfenidone 267 mg Oral Tablet
DRUG
2 trials
Sponsors
Blade Therapeutics
, Vikas Dudeja
Conditions
Chronic Pancreatitis
Drug Drug Interaction
Phase 1
Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers
Completed
NCT04939467
Blade Therapeutics
Drug Drug Interaction
Start: 2021-10-15
End: 2022-04-01
Updated: 2022-04-15
Phase 2
Pirfenidone as Treatment of Chronic Pancreatitis
Not yet recruiting
NCT07755813
Vikas Dudeja
Chronic Pancreatitis
Start: 2026-08-01
End: 2030-08-01
Target: 60
Updated: 2026-08-10
Related Papers
Cudetaxestat, a differentiated phase 2-ready investigational treatment for idiopathic pulmonary fibrosis
2022-09-04
3 citations